Trial
NCT00247403
Safety Study of 2DG With Stereotactic Radiosurgery
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Iowa
Collaborators
—
Condition
Intracranial Neoplasms
Intervention
2-deoxyglucose (2DG)
Why stopped
Pharmaceutical company no longer manufactures drug
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-10